|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01501 INT MEDICAL
Nominal 
30.240 0.000 (0.000%) | 2024/12 - Final RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | 225,544 | 178,146 | 180,460 | 72,756 | 95,713 |
| Net Cash from / (used in) Investing Activities | (187,310) | (283,812) | (316,184) | (268,084) | (221,870) |
| Net Cash from / (used in) Financing Activities | 56,969 | 8,058 | 9,722 | (31,069) | (27,946) |
| Increase / (Decrease) in Cash & Cash Equivalents | 95,203 | (97,608) | (126,002) | (226,397) | (154,103) |
| Cash & Cash Equivalents at beginning of period | 423,668 | 518,266 | 640,550 | 870,132 | 1,036,783 |
| Effect of Foreign Exchange Rate Changes | 3,083 | 3,010 | 3,718 | (3,185) | (12,548) |
| Others | 0 | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | 521,954 | 423,668 | 518,266 | 640,550 | 870,132 |
| Remarks: | Real time quote last updated: 30/10/2025 09:33 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 98,528 |
| %Change | -1.999% |
| EPS / (LPS) | RMB 0.570 |
| NBV Per Share (¥) | RMB 10.659 |